Bank Julius Baer & Co. Ltd, Zurich Eli Lilly & CO Transaction History

Bank Julius Baer & Co. Ltd, Zurich

  • $25.6 Billion
  • Q3 2024

A detailed history of Bank Julius Baer & Co. Ltd, Zurich transactions in Eli Lilly & CO stock. As of the latest transaction made, Bank Julius Baer & Co. Ltd, Zurich holds 641,993 shares of LLY stock, worth $511 Million. This represents 2.22% of its overall portfolio holdings.

Number of Shares
641,993
Previous 686,197 6.44%
Holding current value
$511 Million
Previous $621 Million 8.45%
% of portfolio
2.22%
Previous 2.6%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$772.14 - $960.02 $34.1 Million - $42.4 Million
-44,204 Reduced 6.44%
641,993 $569 Million
Q2 2024

Aug 14, 2024
SELL
$724.87 - $909.04 $24.7 Million - $31 Million
-34,131 Reduced 4.74%
686,197 $621 Million
Q1 2024

May 14, 2024
BUY
$592.2 - $792.28 $97.9 Million - $131 Million
165,326 Added 29.79%
720,328 $560 Million
Q4 2023

May 16, 2024
BUY
$525.19 - $619.13 $285 Million - $337 Million
543,511 Added 4729.88%
555,002 $324 Million
Q4 2023

May 16, 2024
SELL
$525.19 - $619.13 $372 Million - $439 Million
-708,837 Reduced 98.4%
11,491 $6.7 Million
Q4 2023

Feb 02, 2024
BUY
$525.19 - $619.13 $31.8 Million - $37.5 Million
60,538 Added 12.24%
555,002 $324 Million
Q3 2023

Nov 13, 2023
BUY
$434.7 - $599.3 $206 Million - $284 Million
473,704 Added 2281.81%
494,464 $266 Million
Q2 2023

Jul 24, 2023
BUY
$350.74 - $468.98 $7.28 Million - $9.74 Million
20,760 New
20,760 $9.74 Million
Q1 2023

May 11, 2023
SELL
$310.63 - $364.82 $284,226 - $333,810
-915 Reduced 20.39%
3,573 $1.23 Million
Q4 2022

Jan 24, 2023
SELL
$321.55 - $374.67 $215,438 - $251,028
-670 Reduced 12.99%
4,488 $1.64 Million
Q3 2022

Nov 04, 2022
BUY
$296.48 - $337.87 $821,249 - $935,899
2,770 Added 116.0%
5,158 $1.67 Million
Q2 2022

Jul 22, 2022
SELL
$278.73 - $327.27 $206,538 - $242,507
-741 Reduced 23.68%
2,388 $774,000
Q1 2022

May 09, 2022
BUY
$234.69 - $291.66 $687,407 - $854,272
2,929 Added 1464.5%
3,129 $896,000
Q1 2021

May 10, 2021
SELL
$164.32 - $212.72 $153,967 - $199,318
-937 Reduced 82.41%
200 $37,000
Q4 2020

Feb 24, 2021
SELL
$130.46 - $172.63 $150,289 - $198,869
-1,152 Reduced 50.33%
1,137 $192,000
Q4 2020

Feb 12, 2021
SELL
$130.46 - $172.63 $127,720 - $169,004
-979 Reduced 29.96%
2,289 $192,000
Q3 2020

Nov 10, 2020
BUY
$146.22 - $169.13 $137,739 - $159,320
942 Added 40.5%
3,268 $484,000
Q2 2020

Aug 12, 2020
SELL
$136.42 - $164.18 $1.66 Million - $1.99 Million
-12,137 Reduced 83.92%
2,326 $382,000
Q1 2020

May 13, 2020
BUY
$119.05 - $147.35 $1.72 Million - $2.13 Million
14,463 New
14,463 $2.01 Million

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bank Julius Baer & Co. Ltd, Zurich Portfolio

Follow Bank Julius Baer & Co. Ltd, Zurich and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email